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'Abbreviations used in this paper are: DPN
and DPNH-oxidized and reduced cliphosphopyri-
dine nucleotide. TPN and TPNH-oxjdjzed and
reduced triphosphopyridine nucleotide.
MATERIALS AND METHODS
Specimens: Skin strips of approximately 1 to 2
cm by 10 cm were removed from the abdominal
wall at autopsy 6 to 20 hours post-mortem. For
comparative studies, specimens 2 cm by 3 cm
were collected from the sole. After removal, the
specimens were wrapped in sterile gauze moistened
with Krebs-Ringer-phosphate buffer and imme-
diately prepared for the experiments.
In experiments with whole skin, the specimens
were freed of fat and cut into small pieces with
scissors; about 400 mg were incubated in each ex-
periment. To prepare dermis, the skin strip was
stretched to about one and one-half times its
length and a Castroviejo keratome with the depth
of the blade set at 0.1 mm was used to remove the
superficial layer. Microscopic examination showed
that the cut was in the connective tissue below the
basal layer and the epidermis was completely re-
moved. The remaining dermal layer was then cut
into small pieces and approximately 400 mg were
used in each incubation. To obtain epidermis, the
whole skin strip was stretched and the epidermis
was carefully scraped off with a curette. From an
area of 4 cm by 27 cm, 450 mg of epidermis could
be obtained. These scrapings were used in the in-
cubation without further cutting. Histologic sec-
tions showed that the epidermis obtained in this
manner was not entirely free of dermal tissue, al-
though minute in amount.
Incubation: In each experiment, the tissue was
suspended in 7 ml of Krebs-Ringer-phosphate
buffer and incubated for 5 hours in a Dubnoff
shaking incubator at 370 C. with 0.1 ml of an
ethanol solution of hydrocortisone-4-'°C (0.025
iemole containing 1.2 >< 10° dpm of '4C).2 In ex-
periments with coenzymes,' 1 mole of each was
added in 0.1 ml of water. The TPNH-generating
system consisted of 1 emole of TPN, 5 moles of
glucose-6-phosphate and 1 Kornberg unit of glu-
cose-6-phosphate dehydrogenase.
Analysis: The procedures for the extraction of
2 Purchased from Nuclear-Chicago and was Pu-
rified by paper chromatography in the system used
in our analysis. The radioactivity was measured
by a Packard Tri-Carb scintillation counter Model
314 EX.
'The coenzymes, glucose-6-phosphate and glu-
cose-6-phosphate dehydrogenase were purchased
from Sigma Chemical Company.
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of our studies concerning the sites of metab-
olism.
Our previous studies demonstrated the for-
mation of several metabolites after hydrocor-
tisone-4-'°C was incubated with slices of human
skin (1). In a continuation of these studies re-
ported here, it was found that skin specimens
obtained from cadavers several hours after
death lacked most of such metabolic activity.
This lack of activity could be due to deteriora-
tion of enzymes or the loss of necessary co-
factors, or both. The requirement for pyridine
nucleotides in the metabolism of hydroeortisone
by rat kidney and liver had been reported (2—
4). It is conceivable that the levels of these
coenzymes may decline in the skin after death.
In subsequent experiments, a TPNH-generating
system' and DPNH were added to the incuba-
tion mixture of hydrocortisone-4-'°C with sam-
ples of cadaver skin, and the metabolic activity
was revived. This finding enabled us to use
cadaver skin for further studies in which both
the epidermal and dermal layers were found to
metabolize hydrocortisone. Furthermore, a spec-
imen from the sole metabolized hydrocortisone
as well. Since the sebaceous glands and hair
follicles are absent in this tissue, it appears
that the presence of these structures are not
an obligatory requirement for the metabolism
of hydrocortisone. This paper presents the cvi-
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FIG. 1. Distribution of 140 in paper chromatograms after hydrocortisone4.?4C was in-
cubated with cadaver skin. Tracing A is the result obtained without added coenzymes; B
with added TPNH-generating system; C a control in which the skin was boiled before
incubation with added TPNH-generating system; D with added DPNH; E with both
TPNH and DPNH added.
radioactive materials from the incubates and the
chromatographic method were described previ-
ously (1). The distribution of 140 in the chro-
matogram was determined by a Vanguard Auto-
scanner 880 with recorder and automatic data
system. As in the previous work, the peaks in the
tracings corresponding to the radioactive areas in
the paper chromatogram were designated with Ro-
man numerals. Freshly purified hydrocortisone-4-
140 exhibits a single Peak JJJ4 The relative
amount of 140 in each area except Peak III was
Radioactive steroids are notoriously unstable.
Hydrocortisone-4-14C decomposes in storage and
during incubation with the buffer (1), hence addi-
tional Peaks I and II may be detected. The de-
composition can be minimized by exclusion of
light and storage at low temperatures in the dark.
The amount of 140 in Peak III was usually
much greater than in other areas, and accurate
measurement could not be obtained by using the
same scale. Approximate value could be obtained
expressed in percentage of the total 140 applied
to the paper. This total 140 usually accounted for
about 94—98% of the 1C used in the incubation.
EXPERIMENTS AND RESULTS
Abdominal Skin: Slices of whole skin from
the abdominal wall of cadavers were studied
in five experiments. The Vanguard tracings
from these experiments are shown in Figure 1.
In Experiment A, the skin slices were incubated
with hydrocortisone-4-14C without added co-
enzyme, while in Experiment B the TPNH-
generating system was included in the incuba-
tion mixture. Tracing B has five distinct peaks:
I, II, III, V and VI, and is quite similar to
by deduction of the values of other areas from
the total.
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tracings previously obtained in studies with
surgical specimens (1). Peak IV which has been
found only after incubation with foreskin (1)
is not present in tracing B. Tracing A has
three peaks, I, II and ITT. The size of Peak II
is smaller (2.5%) as compared with Peak II in
tracing B (4.6%) and Peaks V and VI are not
present. Experiment C was a control in which
the skin was boiled before incubation with hy-
drocortisone-4-14C in the presence of the
TPNH-generating system. The results, as shown
by tracing C, are similar to those obtained
previously with boiled skin without the added
TPNH-generating system (1). Thus the TPNII-
generating system has no effect on hydro-
cortisone without the active enzymes of the
skin. These experiments established the effect
of TPNH in restoring the ability of cadaver
skin to metabolize hydrocortisone. The effect
of DPNH was tested in Experiment D, and
tracing D shows a larger Peak 11(7.2%) while
Peaks V and VI are smaller than in B. The
combined effect of TPNH and DPNH is shown
in tracing E. Except in Peak II, the combined
effect is somewhat greater than either coenzyme
alone, but apparently is not additive of the
effects of the single coenzymes.
The effects of the oxidized pyridine nucleo-
tides were also studied. It was found that DPN
particularly increased the size of Peak II, while
TPN was less effective. They were both in-
effective in enhancing metabolic changes rep-
resented by the other peaks.
These experiments were repeated a number
of times with specimens obtained 6 to 20 hours
after death. The results were qualitatively re-
producible each time.
It was of serious concern that skin flora
might contribute to the observed metabolic
changes of hydrocortisone. Experiment B was
repeated with the addition of 700 units of
penicillin and 700 g of streptomycin to the
incubation mixture. The results of metabolism
were indistinguishable from those shown in
tracing B. After the incubation an aliquot of
the mixture was plated on eosin-methylene blue
agar and blood agar. There was no bacterial
growth after 48 hours of aerobic incubation. A
few colonies of Corynebacterium aenes grew out
after 4 days of anaerobic incubation on brain
heart infusion agar. The organism was har-
vested and incubated with hydrocortisone-4-14C
in Krebs-Ringer-phosphate buffer with added
TPNH-generating system. No metabolic change
of the radioactive steroid was detected.
The Sole: Figure 2 shows the results of a
study with a specimen of the sole with the
added TPNH-generating system. Peaks II, V
and VI are relatively larger in this tracing. A
freshly purified sample of hydrocortisone-4-'4C
was used in this experiment, and Peak I was
absent. In experiments using hydrocortisone-
4-"C which had been in storage, Peak I was
larger as in other tracings.
Dermis: Dermis in the presence of TPNH
produced virtually all the metabolic changes
observed in whole skin. The results are shown
by the lower tracing in Figure 3. The upper
tracing shows the results of incubation without
the added TPNH-generating system; Peak II
is smaller and Peaks V and VI are insignificant.
Epidermis: Figure 4 shows the results of a
study with 450 mg of epidermis obtained from
the abdominal wall of a cadaver. Active
metabolism is apparent in the presence of added
TPNH-generating system. The size of Peak
VI (1.7%), is larger than observed in whole
skin and dermis while Peak V is relatively
smaller (0.8%). Because the preparation of
epidermis was not entirely free of dermis, a
control experiment was carried out using 50
mg of dermis. Peaks V and VI were not de-
tected in the tracing. Since the amount of
dermis remaining with the epidermis was con-
siderably less than 50 mg, the possibility that
the observed metabolic activity of the epidermis
FIG. 2. Tracing obtained after hydrocortisone-4-14C was incubated with a specimen from
the sole in the presence of added TPNH-generating system.
SOLE+TPNH
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Fia. 3. Tracings obtained after incubation of hydrocortisone-4-14C with dermis. Upper
tracing was obtained without added coenzyme. Addition of TPNII-generating system
increased the metabolism as shown by lower tracing.
FIG. 4. Tracing obtained after incubation of hydrocortisone-4-14C with epidermis in the
presence of added TPNII-generating system.
might be due to contaminating dermis was thus
eliminated.
In another experiment 110 mg of epidermis
was used in the incubation. Active metabolism
was indicated by Peaks II (3.0%), and VI
(0.9%), but Peak V was not discernible. For
comparison, 100 mg of dermis was incubated
in the same manner. Peaks V and VI were both
missing in the tracing although metabolic ac-
tivity was evidenced by Peak II (3%). These
experiments indicate that on the basis of equal
weights, epidermis appears to be more active
in metabolizing hydrocortisone than dermis es-
pecially in the formation of the metabolite (a)
represented by Peak VI.
DISCUSSION
The requirement for reduced nucleotides in
the metabolism of hydrocortisone by human
skin is demonstrated by these experiments. The
inability of cadaver skin to metabolize hydro-
cortisone was previously observed (5). Based
on the results of the present study this now
can be explained as due to lack of the eoenzymes.
This explanation is supported by the finding
that addition of the TPNH-generating system
to the incubation mixture restored the metab-
olism. That the observed effect is necessarily
catalyzed by enzymes was further supported
by Experiment C in which the skin was boiled
before incubation, and the TPNH-generating
system was found to have no effect on the
hydrocortisone. Although DPNH was less ef-
fective in restoring metabolism, DPNII and
TPNH combined were more effective than
either nucleotide alone. The effect of DPN and
TPN in enhancing the metabolic activity rep-
resented by Peak II, but not by other peaks,
indicates that several enzymes may be involved
which have different requirements for coen-
zymes.
These experiments also confirm the loss of
DPNH and TPNH in the skin after death. The
loss may be due to destruction by specific en-
zymes (DPNase and nucleotide pyrophos-
phatases) or due to exhaustive utilization by
redox enzyme systems in the absence of an
operative regenerating system.
The known urinary metaboliteS of hydrocor-
tisone are mostly products of reduction (6), as
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are several known metabolites of the liver (3)
and of extrahepatic tissues (7, 8). The finding
that TPNH and DPNH enhance the metabolism
of hydrocortisone in the present study indicates
that the metabolites in human skin may also
be products of reduction, their formation be-
ing catalyzed by enzymes using reduced pyri-
dine nucleotides as the hydrogen donors. This
view is supported by our recent identification
of several of these metabolites (9). Several
steroid hydroxylases are known to require mo-
lecular oxygen and TPNH for action (1O-12).
Whether or not the skin contains a hydro-
cortisone hydroxylase linked to TPNH is not
known. It is of interest that DPN and TPN
enhance the formation of the metabolite in
Peak II. Dehydrogenation of hydrocortisone
was thus indicated and was later confirmed by
the identification of cortisone as a metabolite
(9). Since other enzyme systems utilizing pyri-
dine nucleotides may be operative in the skin,
they may obscure the observation of the specific
requirement of coenzymes in each of the met-
abolic changes of hydrocortisone. Such specific
information and other details of the mechanism
of the metabolism can be obtained only after
the individual enzymes are characterized.
With the addition of coenzymes to the in-
cubation mixture, it was possible to establish
in vitro that both the epidermal and dermal
layers can metabolize hydrocortisone. On the
basis of equal weights, epidermis appears to
be more active in metabolizing hydrocortisone
especially in the formation of metabolite(s)
represented by Peak VI. Since epidermis con-
stitutes only a minor part of the weight of
whole skin, dermis probably contributes more
to the overall metabolism of hydrocortisone in
the skin. The experiment utilizing the skin of
the sole showed that it is also active in me-
tabolizing hydrocortisone although it is devoid
of sebaceous glands and hair follicles, indicating
that these structures are not necessary for the
metabolism; whether or not they can metab-
olize hydrocortisone is not shown by this ex-
periment.
SUMMARY
1. In vitro studies showed that the human
skin loses its ability to metabolize hydrocorti-
sone-4-14C a few hours after death. Addition
of a TPNH-generating system to the incuba-
tion medium restored the metabolic activity.
Addition of DPNH was less effective, while
addition of DPN and TPN restored only a
specific part of the metabolism.
2. Both the dermis and epidermis were found
capable of metabolizing hydrocortisone-4-'4C.
3. The sole was found to metabolize hy-
drocortisone as well, indicating that sebaceous
glands and hair follicles are not necessary for
the metabolism.
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DISCUSSION
DR. JoHN R. HASERICK (Cleveland, Ohio):
I am interested in the relationship between
inflammation and the metabolism of corticos-
teroids. All of us have known for some time
that some diseases in their active stages seem
to "metabolize" steroids. In cases of pemphigus
and acute lupus erythematosus tremendous
doses of steroids may be required at first to
control the disease. Later, as the condition im-
proves and the patient gets well, progressively
smaller doses are required. We have all seen
the phenomenon of the patient with an active
disease process receiving large doses of steroids
seemingly without evidence of steroidal side ef-
fects. Yet, when the disease becomes inactive
in the same patient receiving the same dose of
steroids typical side effects of the drug suddenly
develop, i.e., it appears that the activity of the
disease is no longer "neutralizing" the steroids.
It seems to me that Dr. Hsia's studies may
provide us with a way of measuring this utiliza-
tion of steroids by inflammatory processes. I
should like to ask him if he has done any work
on the metabolization or utilization of steroids
in actively pathologic skin.
DR. IRvIN M. FREEDBERG (Boston, Mass.):
Are the metabolites which you have measured
active? Do you have any idea of their struc-
ture?
DR. S. L. HsIA (in closing): I will answer
the second question by Dr. Freedberg first.
We now know what these metabolites are, we
know most of them if not all of them; and
reported on their identification at the recent
Federation Meeting in Atlantic City (Federa-
tion Proc. 4: 574, 1965). I think I had better
show these in the accompanying figure.
The major metabolite is cortisone, formed by
oxidation of the 11-f3-ol to the 11-one, and it
is indicated by Peak II. The other metabolites
identified are all reduction products. The 20-
keto group in the side chain of hydrocortisone
CH2OH
Hydrocortisone
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or cortisone is reduced to the 20a-ol and 20/-ol
to form Reichstein's Substances epi-E and E,
indicated by Peak VI; and epi-TJ and U, in-
dicated by Peak V. So far we have found allo-
dihydrocortisol (Peak II) and allotetrahydro-
cortisol (Peak IV) only after incubation of
hydrocortisone with foreskin and not with skin
from other sites. This is interesting; there
seems to be a biochemical difference in skin of
different sites.
In answer to the question of Dr. Haserick
about comparison of normal and pathological
specimens, we have given the problem much
thought. The stumbling-block in carrying out
such a study is the requirement for relatively
large amounts of skin. We need about 400 mg of
skin for a satisfactory measurement of me-
tabolism. I am trying to increase the sensitivity
of our method, so that we will be able to use
regular biopsy specimens for a comparative
study of normal and pathological skin. This
is an interesting aspect of the study and we
hope to be able to do something about it before
too long.
